Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q4 2022 vs. Q3 2022
How the institutions holding Cidara Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 42 | 42 | 0 |
| Shares | 27.1M | 26.6M | −423.4K (−1.6%) |
| Value | $17.1M | $20.2M | +$3.09M (+18.1%) |
New holders (9)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 301,612 | $228.1K | 0.00% |
| Callan Capital, LLC | 103,462 | $78.2K | 0.01% |
| Jane Street Group, LLC | 62,482 | $47.3K | 0.00% |
| Money Concepts Capital Corp | 55,000 | $41.6K | 0.00% |
| Level Four Advisory Services, LLC | 27,927 | $21.1K | 0.00% |
| StoneX Group Inc. | 15,000 | $11.3K | 0.00% |
| ACT Advisors, LLC. | 13,866 | $10.5K | 0.01% |
| Bank of America Corp | 151 | $114 | 0.00% |
| Royal Bank of Canada | 15 | $0 | 0.00% |
Sold out (9)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Knott David M Jr | 686,027 | $431.0K |
| Monashee Investment Management LLC | 369,099 | $232.0K |
| Bridgeway Capital Management, LLC | 140,000 | $88.0K |
| Two Sigma Securities, LLC | 41,819 | $26.0K |
| Advisor Group Holdings, Inc. | 22,000 | $14.0K |
| Virtu Financial LLC | 20,889 | $13.0K |
| HSBC Holdings PLC | 17,001 | $11.0K |
| Raymond James & Associates | 11,672 | $7.00K |
| Group One Trading, L.P. | 405 | $0 |